spacer
home > pmps > spring 2004 > achieve controlled release and increased bioavailability of pharmaceutical compounds through spray drying
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Achieve Controlled Release and Increased Bioavailability of Pharmaceutical Compounds Through Spray Drying

The recent interest in highly potent but poorly soluble pharmaceutical compounds has made controlled release and enhanced bioavailability of critical importance for many pharmaceutical dosage forms. This article describes spray drying techniques for manufacturing of products achieving controlled release and/or enhanced bioavailability. Four main categories of products are investigated, nano particles, microencapsulation, solid amorphous dispersions and dry emulsions.

Spray Drying

Spray drying is a very fast method of drying due to the large product surface area and high heat transfer coefficients available. The large surface area also allows for drying at a moderate to low temperature. These properties make spray drying feasible for heat sensitive materials. Rapid drying, and consequently fast stabilisation of feed material, makes spray drying ideally suited for encapsulation and producing dry emulsions or amorphous material. Particle engineering possibilities also include powder performance characteristics, such as aerodynamic particle size, geometric particle size, particle size distribution and powder flow properties.

Nano Particles

Spray drying of nano particles involves drying a suspension of nano particles in a suitable liquid, for example water. By spray drying, the primary particle size can be preserved and at the same time new desirable powder properties can be achieved. For example, powder with good flow properties and reduced tendency to produce air born dust or low aerodynamic particle size, combined with good powder flow properties.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
2
     

There are no comments in regards to this article.

spacer
By Henrik Schwartzbach, Pharma Division Process Technologist at Niro A/S

Henrik Schwartzbach joined Niro A/S in 1992, working in R&D and process optimisation. He has detailed and in-depth knowledge of cutting-edge pharmaceutical spray drying. As the Niro A/S Pharma Division Process Technologist, Henrik is deeply involved in setting the industry standards for pharmaceutical spray drying.
spacer
Henrik Schwartzbach
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

First-in-Human Workshop

7-8 May 2012, Berlin, Germany


More info >>

 
News and Press Releases

Firstan Ltd are first to achieve the new Pharmaceutical PS9000:2011 quality standard

Firstan Ltd, the UK’s leading independently owned Pharmaceutical and Food Carton producer have become the first UK Packaging company to achieve the new Pharmaceutical PS9000:2011 quality standard for its Healthcare Division. This standard was published in September 2011 in consultation with industry suppliers, pharmaceutical companies and other stakeholder organisations. Firstan have held the Pharmaceutical accreditation for almost 20 years.  
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.